Investing-News.Com
Information for Investors

CELL THERAPEUTICS, (CTIC) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

CELL THERAPEUTICS, (CTIC) Stock Rating Learn More

Our Overall Rating on Cell Therapeutics Inc,  CTIC is STRONG BUY
StockPickReport.Com research suggests CTIC's price will move significantly higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move up.

Investors, traders, and other market participants may find this a good opportunity to buy CTIC, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains.

Trading volume seems to be going up and CTIC's closing price moved up during the week before this rating was initiated.

Our STRONG BUY Rating on CTIC was issued on 03/25/08

CELL THERAPEUTICS Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces CELL THERAPEUTICS Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in CELL THERAPEUTICS buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on CELL THERAPEUTICS. This software is specially designed to give precision entry and exit points on CELL THERAPEUTICS, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When CELL THERAPEUTICS Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even CELL THERAPEUTICS, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: day trading forum  how to read stock chart  symbol  investing tip stock market 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Zevalin Data to be Presented at ASH 2008 (PR Newswire)

FDA speeds up review of Cell Therapeutics drug (at bizjournals.com)

Cell Therapeutics gets FDA priority review on drug (AP)

Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009 (Business Wire)

Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides (PR Newswire)

FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review (PR Newswire)

Cell Therapeutics, Spectrum in deal to sell Zevalin (at bizjournals.com)

CELL THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Finan (EDGAR Online)

Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals (PR Newswire)

Spectrum and Cell Therapeutics to market Zevalin (AP)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.